Search by Drug Name or NDC

    NDC 55566-9800-02 Rebyota 50000000000 [CFU]/150mL Details

    Rebyota 50000000000 [CFU]/150mL

    Rebyota is a RECTAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is DONOR HUMAN STOOL.

    Product Information

    NDC 55566-9800
    Product ID 55566-9800_80beb793-bf8c-4a85-96d7-46a0d270f4c7
    Associated GPIs
    GCN Sequence Number 084129
    GCN Sequence Number Description fecal microbiota, live-jslm ENEMA 150 ML RECTAL
    HIC3 D6P
    HIC3 Description FECAL MICROBIOTA TRANSPLANTATION (FMT)
    GCN 53279
    HICL Sequence Number 048488
    HICL Sequence Number Description FECAL MICROBIOTA, LIVE-JSLM
    Brand/Generic Brand
    Proprietary Name Rebyota
    Proprietary Name Suffix n/a
    Non-Proprietary Name Donor Human Stool
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route RECTAL
    Active Ingredient Strength 50000000000
    Active Ingredient Units [CFU]/150mL
    Substance Name DONOR HUMAN STOOL
    Labeler Name Ferring Pharmaceuticals Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125739
    Listing Certified Through 2024-12-31

    Package

    NDC 55566-9800-02 (55566980002)

    NDC Package Code 55566-9800-2
    Billing NDC 55566980002
    Package 1 CARTON in 1 CARTON (55566-9800-2) / 1 BAG in 1 CARTON (55566-9800-1) / 150 mL in 1 BAG (55566-9800-0)
    Marketing Start Date 2023-01-09
    NDC Exclude Flag N
    Pricing Information N/A